19-May-2020 | Facts and Factors
Findings from Facts and Factors report “Hypopigmentation Disorder Treatment Market by treatment (topical drugs, laser, chemical peels, microdermabrasion and others (phototherapy, etc.)), disease indication (Vitiligo, albinism, and others), and end-user (hospitals, aesthetic clinics & dermatology centers, and others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Hypopigmentation Disorder Treatment market in 2019 was approximately USD 3,816.2 Million. The market is expected to grow above a CAGR of 5.2% and is anticipated to reach over USD 5,384.2 Million by 2026.
Hypopigmentation is a lack of pigment on the skin or light. This may occur or be put all over the body. Several patches or areas on the skin can appear white at localized hypopigmentation. Patch size and shape can differ considerably. And the melanin itself decreases in individuals with hypopigmentation. Hypopigmentation can also be caused by a reduction in amino acid tyrosine. Melanocytes produce tyrosine for the development of melanin. Hypopigmentation may occur in people of all races, but in people with darker skin, it may be more apparent due to the dissimilarity between natural skin color and white patches. Hypopigmentation triggers several different causes. The most common condition occurs as a result of skin injury or trauma. Blisters, burns, and infections may all cause skin damage and hypopigmentation. Cosmetic skin treatments such as chemical or laser peeling can also cause hypopigmentation if the procedure is improperly performed.
Growing lifestyle spending, as well as rising understanding among humans, drives growth in the market for the treatment of pigmentation disorders. In addition, the growing prevalence of skin disorders is driving the rise in demand for treating hypopigmentation disorder. The market for the treatment of hypopigmentation disorders is expected to increase by growing the aging population and rising people concerned with improving the affected skin. The growing demand for treatment with pigmentation disorder is combined with the rising number of people affected by pigmentation disorders, which in turn triggers the growth of the market for treatment for pigmentation disorder.
Browse the full “Hypopigmentation Disorder Treatment Market by treatment (topical drugs, laser, chemical peels, microdermabrasion and others (phototherapy, etc.)), disease indication (Vitiligo, albinism, and others), and end-user (hospitals, aesthetic clinics & dermatology centers, and others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/hypopigmentation-disorder-treatment-market-by-treatment-topical-drugs
The Hypopigmentation Disorder Treatment market is segmented into treatment, disease indication, end-user and region segment. The treatment segment is segmented into topical drugs, laser, chemical peels, microdermabrasion and others (phototherapy, etc.). The disease indication segment is divided into Vitiligo, albinism, and others. The end-user segment is segmented into hospitals, aesthetic clinics & dermatology centers, and others. In 2019, the Segment of cosmetic clinics & dermatology centers dominated the global market. The phenomenon is likely to continue over the forecast period. Factors that drive the segment are increasing the number of qualified doctors who can perform cosmetic procedures to treat pigmentation disorders and the number of patients with skin pigmentation is increasing.
Geography wise, the market is segmented into North America, Europe, Assia Pacific, Latin America and Middle East and Africa. North America is powered by increased incidence of hypopigmentation conditions, new product approvals, a large product pipeline and increased spending on health care. The demand for treating hypopigmentation disorder in Asia Pacific is expected to grow rapidly over the forecast period. In 2019 China dominated the region's market due to a large number of vitiligo patients.
Top key players operating in the market are Allergan, Alvogen, Episciences Inc., Obagi Cosmeceuticals LLC, Pierre Fabre, Rxi Pharmaceutical Corporation and SkinCeuticals amongst others.
This report segments the Hypopigmentation Disorder Treatment market as follows:
Global Hypopigmentation Disorder Treatment Market: Treatment Segment Analysis
- Topical Drugs
- Chemical Peels
- Others (phototherapy, etc.)
Global Hypopigmentation Disorder Treatment Market: Disease Indication Segment Analysis
Global Hypopigmentation Disorder Treatment Market: End user Segment Analysis
- Aesthetic Clinics & Dermatology Centers
Global Hypopigmentation Disorder TreatmentMarket: Regional Segmentation Analysis
- North America
- The UK
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
Rest of Middle East & Africa
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Facts & Factors
Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450
Email: [email protected]